Clinical trial · Observational
Laboratory Studies Into the Pathology of Leukaemia
NCT03233763CI-TRIAL-00028842unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Ongoing laboratory work into the pathology of Leukaemia:
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Leukemia | Leukemia | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Bone Marrow Aspirate | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Pathology of Leukaemia cells
- timeFrame
- 15 years
- description
- Pathology of Leukaemia cells
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 18 \& Over Diagnosis of AML Generic Research consent given Exclusion Criteria: Under 18 No generic research consent
References
Publications (0)
Data not yet available
No reference posted for this study.